| Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris, ... JAMA Network Open 5 (9), e2231982-e2231982, 2022 | 86 | 2022 |
| Effects of heterozygous variants in the leptin-melanocortin pathway on Roux-en-Y gastric bypass outcomes: a 15-Year case–control study A Campos, L Cifuentes, A Hashem, B Busebee, MD Hurtado-Andrade, ... Obesity surgery 32 (8), 2632-2640, 2022 | 24 | 2022 |
| Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ... EClinicalMedicine 58, 2023 | 21 | 2023 |
| Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Netw Open. 2022; 5 (9): e2231982 W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris | 6 | |
| Association between food intake and gastrointestinal symptoms in patients with obesity W Ghusn, L Cifuentes, A Campos, D Sacoto, A De La Rosa, F Feris, ... Gastro hep advances 2 (1), 121-128, 2023 | 5 | 2023 |
| Cardiovascular risk and diseases in patients with and without leptin-melanocortin pathway variants L Cifuentes, A Campos, D Sacoto, W Ghusn, A De la Rosa, F Feris, ... Mayo Clinic Proceedings 98 (4), 533-540, 2023 | 4 | 2023 |
| Refractory Escherichia coli pneumonia: A case report SA Khalafi, ADLR Vaquez, F Dihowm Cureus 15 (2), 2023 | 4 | 2023 |
| A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center A De la Rosa, W Ghusn, D Sacoto, A Campos, L Cifuentes, F Feris, ... Obesity Pillars 4, 100046, 2022 | 4 | 2022 |
| Sex as an independent variable in the measurement of satiation: a retrospective cohort study MD Hurtado, L Cifuentes, A Campos, A De La Rosa, E Kapoor, ... International Journal of Obesity 46 (12), 2156-2162, 2022 | 3 | 2022 |
| Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, ... International Journal of Obesity, 1-6, 2024 | 2 | 2024 |
| The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes W Ghusn, S Fansa, D Anazco, E Tama, L Cifuentes, K Gala, ... Diabetes, Obesity and Metabolism 26 (6), 2167-2175, 2024 | 1 | 2024 |
| The effect of heterozygous gene variants of the leptin-melanocortin pathway on weight loss following sleeve gastrectomy F Feris, W Ghusn, A Campos, L Cifuentes, A De la Rosa, D Sacoto, ... Obesity Surgery 33 (7), 2246-2249, 2023 | 1 | 2023 |
| Type 2 Diabetes Remission in Patients with Leptin-Melanocortin Pathway Variants after Gastric Bypass D Anazco, W Ghusn, S Fansa, E Tama, A Campos-Martinez, L Cifuentes, ... OBESITY 31, 29-30, 2023 | | 2023 |
| The Individualized Metabolic Surgery Score Predicts Weight Loss in Patients with T2DM on Semaglutide W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... OBESITY 31, 82-83, 2023 | | 2023 |
| A Case Report of Cytarabine-Induced Red Ear Syndrome M Botros, A De La Rosa, S Nadella, AY Chang, SS Maharaj Cureus 15 (11), 2023 | | 2023 |
| S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study W Ghusn, D Anazco, S Fansa, E Tama, A De La Rosa, B Nicolalde, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1632 Effect of Changes in Gastric Emptying and Low-Calorie Phenotype Tailored Diet on Weight Loss: Results From a 12-week Clinical Trial L Cifuentes, W Ghusn, A Campos, F Feris, D Sacoto, A De la Rosa, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| Uso bem-sucedido de rivaroxabana com níveis terapêuticos de antifator xa em paciente com obesidade mórbida e embolia pulmonar aguda de risco intermediário-alto K Dah, M Porres-Aguilar, AD Rosa, S Prakash Jornal Vascular Brasileiro 22, e20230056, 2023 | | 2023 |
| Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism K Dah, M Porres-Aguilar, AD Rosa, S Prakash Jornal Vascular Brasileiro 22, e20230056, 2023 | | 2023 |
